Pizzie Nick
SEC insider (Form 3/4/5 filer). CIK 0001742143. Chief Financial Officer at Axsome Therapeutics, Inc. (AXSM). 13 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in NEW YORK, NY.
Companies Pizzie Nick has filed insider reports for
- Axsome Therapeutics, Inc. (AXSM): Officer, Chief Financial Officer
Pizzie Nick
CIK: 0001742143
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Axsome Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 9, 2026AXSM
Axsome Therapeutics, Inc.
ExerciseDirect33K shares at avg. $3.50$116K - Jun 9, 2026AXSM
Axsome Therapeutics, Inc.
SaleDirect33K shares at avg. $240.09$7.9M - Apr 21, 2026AXSM
Axsome Therapeutics, Inc.
AwardDirectPerformance Stock Units
8.2K shares- - Feb 26, 2026AXSM
Axsome Therapeutics, Inc.
AwardDirectRestricted Stock Units
18.6K shares- - Jan 22, 2026AXSM
Axsome Therapeutics, Inc.
ExerciseDirect12K shares at avg. $3.50$42K - Jan 22, 2026AXSM
Axsome Therapeutics, Inc.
SaleDirect12K shares at avg. $187.92$2.3M - Feb 24, 2025AXSM
Axsome Therapeutics, Inc.
AwardDirectPerformance Stock Units
9.4K shares- - Feb 21, 2025AXSM
Axsome Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
9.5K shares- - Feb 21, 2025AXSM
Axsome Therapeutics, Inc.
AwardDirectRestricted Stock Units
9.4K shares- - Feb 14, 2025AXSM
Axsome Therapeutics, Inc.
SaleDirect3K shares at avg. $131.07$393K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 9, 2026 | AXSM Axsome Therapeutics, Inc. | Exercise | 33,000 | $3.50 | $115,500 | Direct |
| Jun 9, 2026 | AXSM Axsome Therapeutics, Inc. | Sale | 33,000 | $240.09 | $7,922,970 | Direct |
| Apr 21, 2026 | AXSM Axsome Therapeutics, Inc. | Award Performance Stock Units | 8,188 | - | - | Direct |
| Feb 26, 2026 | AXSM Axsome Therapeutics, Inc. | Award Restricted Stock Units | 18,570 | - | - | Direct |
| Jan 22, 2026 | AXSM Axsome Therapeutics, Inc. | Exercise | 12,000 | $3.50 | $42,000 | Direct |
| Jan 22, 2026 | AXSM Axsome Therapeutics, Inc. | Sale | 12,000 | $187.92 | $2,255,040 | Direct |
| Feb 24, 2025 | AXSM Axsome Therapeutics, Inc. | Award Performance Stock Units | 9,423 | - | - | Direct |
| Feb 21, 2025 | AXSM Axsome Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 9,516 | - | - | Direct |
| Feb 21, 2025 | AXSM Axsome Therapeutics, Inc. | Award Restricted Stock Units | 9,423 | - | - | Direct |
| Feb 14, 2025 | AXSM Axsome Therapeutics, Inc. | Sale | 3,000 | $131.07 | $393,210 | Direct |
1-10 of 13 transactions